Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EV/Core EBITDA

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 32.66153.69244.10

What is the latest EV/Core EBITDA ratio of GENPHARMASEC ?

The latest EV/Core EBITDA ratio of GENPHARMASEC is 32.66 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202532.66
Mar2024153.69
Mar2023244.10

How is EV/Core EBITDA of GENPHARMASEC Trending?

Years EV/Core EBITDA % Change
Mar2025 32.66
-78.75
Mar2024 153.69
-37.04
Mar2023 244.1 -

Other Financial Ratios of GENPHARMASEC


Compare EV/Core EBITDA ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹73.6 Cr 3.1% 10.8% -41.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,073.5 Cr -2.1% 2% 2.8% Stock Analytics
KIRI INDUSTRIES ₹2,740.3 Cr -0.2% -0.4% -13.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,541.6 Cr -3.2% -2.7% -30.5% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,032.1 Cr -10% -6.2% 5% Stock Analytics
BODAL CHEMICALS ₹595.1 Cr -1.7% 0.4% -19.3% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

3.1%

10.8%

-41.3%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses